Reviews |
From the Imperial College London (S.B.M.), National Heart and Lung Institute, London, UK, and Department of Cardiovascular Medicine (C.S.R.), University of Oxford, UK.
Correspondence to Steven B. Marston, Imperial College London, National Heart and Lung Institute, Dovehouse St, London SW3 6LY, UK. E-mail S.Marston{at}imperial.ac.uk
This Review is part of a thematic series on Regulatory Signaling by Thin Filament Modulation, which includes the following articles:
Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications
Modulation of Thin Filament Activation by Crossbridges
Covalent and Noncovalent Modification of Thin Filament Action: The Essential Role of Troponin in Cardiac Muscle Regulation
At the Crossroads of Myocardial Signaling: The Role of Z-Disks in Intracellular Signaling and Cardiac Function
R. John Solaro Guest Editor
In the heart, the contractile apparatus is adapted to the specific demands of the organ for continuous rhythmic contraction. The specialized contractile properties of heart muscle are attributable to the expression of cardiac-specific isoforms of contractile proteins. This review describes the isoforms of the thin filament proteins actin and tropomyosin and the three troponin subunits found in human heart muscle, how the isoform profiles of these proteins change during development and disease, and the possible functional consequences of these changes. During development of the heart, there is a distinctive switch of isoform expression at or shortly after birth; however, during adult life, thin filament protein isoform composition seems to be stable despite protein turnover rates of 3 to 10 days. The pattern of isoforms of actin, tropomyosin, troponin I, troponin C, and troponin T is not affected by aging or heart disease (ischemia and dilated cardiomyopathy). The evidence for proteolysis of thin filament proteins in situ during ischemia and stunning is evaluated, and it is concluded that C-terminal cleavage of troponin I is a feature of irreversibly injured myocardium but may not play a role in reversible stunning.
Key Words: actin troponin tropomyosin calpain stunning
This article has been cited by other articles:
![]() |
D. H. Perlman, S. M. Bauer, H. Ashrafian, N. S. Bryan, M. F. Garcia-Saura, C. C. Lim, B. O. Fernandez, G. Infusini, M. E. McComb, C. E. Costello, et al. Mechanistic Insights Into Nitrite-Induced Cardioprotection Using an Integrated Metabolomic/Proteomic Approach Circ. Res., March 27, 2009; 104(6): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Belin, M. P. Sumandea, T. Kobayashi, L. A. Walker, V. L. Rundell, D. Urboniene, M. Yuzhakova, S. H. Ruch, D. L. Geenen, R. J. Solaro, et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2344 - H2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Biesiadecki and R. J. Solaro When Hearts Fail So Does Skeletal Muscle: Breaking a Vicious Cycle Circ. Res., June 23, 2006; 98(12): 1456 - 1458. [Full Text] [PDF] |
||||
![]() |
M. Adamcova, M. Sterba, T. Simunek, A. Potacova, O. Popelova, and V. Gersl Myocardial regulatory proteins and heart failure Eur J Heart Fail, June 1, 2006; 8(4): 333 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Gao, T. Dai, and D. Nyhan Increased cross-bridge cycling rate in stunned myocardium Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H886 - H893. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, J.-B. Liu, K. M. Horak, H. Zheng, A. R.K. Kumarapeli, J. Li, F. Li, A. M. Gerdes, E. F. Wawrousek, and X. Wang Intrasarcoplasmic Amyloidosis Impairs Proteolytic Function of Proteasomes in Cardiomyocytes by Compromising Substrate Uptake Circ. Res., November 11, 2005; 97(10): 1018 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Arteaga, C. M. Warren, S. Milutinovic, A. F. Martin, and R. J. Solaro Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2183 - H2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sawicki, H. Leon, J. Sawicka, M. Sariahmetoglu, C. J. Schulze, P. G. Scott, D. Szczesna-Cordary, and R. Schulz Degradation of Myosin Light Chain in Isolated Rat Hearts Subjected to Ischemia-Reperfusion Injury: A New Intracellular Target for Matrix Metalloproteinase-2 Circulation, July 26, 2005; 112(4): 544 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg and M. C. Schaub Cellular mechanisms in sympatho-modulation of the heart Br. J. Anaesth., July 1, 2004; 93(1): 34 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Moss, M. Razumova, and D. P. Fitzsimons Myosin Crossbridge Activation of Cardiac Thin Filaments: Implications for Myocardial Function in Health and Disease Circ. Res., May 28, 2004; 94(10): 1290 - 1300. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |